Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
257M
-
Number of holders
-
970
-
Total 13F shares, excl. options
-
235M
-
Shares change
-
-3M
-
Total reported value, excl. options
-
$50.5B
-
Value change
-
-$679M
-
Put/Call ratio
-
1.1
-
Number of buys
-
532
-
Number of sells
-
-396
-
Price
-
$214.89
Significant Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q1 2021
1,126 filings reported holding VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock as of Q1 2021.
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) has 970 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 235M shares
of 257M outstanding shares and own 91.58% of the company stock.
Largest 10 shareholders include BlackRock Inc. (24.2M shares), VANGUARD GROUP INC (20.4M shares), PRICE T ROWE ASSOCIATES INC /MD/ (16.5M shares), STATE STREET CORP (11.2M shares), FMR LLC (10.2M shares), Capital World Investors (9.66M shares), WELLINGTON MANAGEMENT GROUP LLP (8.09M shares), ALLIANCEBERNSTEIN L.P. (7.86M shares), Capital International Investors (6.04M shares), and Clearbridge Investments, LLC (5.52M shares).
This table shows the top 970 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.